Niqris

The Unani medicines have proven its own importance regarding its affectivity, cost and minimal side effects for many illnesses. The general treatment of Gout in Unani system of medicine (USM) comprises of moderating the alter humours (akhlat), excretion of excessive & altered humours, correction of digestion & regulation of metabolism and subside the local inflammation. For this purpose, the medicines having properties like, demulcent (mulattif), concoctive (munzij), diuretic (mudir-e-boul), digestive tonic (muqawwi-e-meda) and anti-inflammatory (muhallil-e-auram) are used. There are so many drugs to treat Gout without causing any side effect but most of these drugs have not been studied on modern scientific parameters, so keeping the fact in mind the formulation comprises of drugs Chobchini (Smilax china), Surinjan Shirin  (Colchicum latium), Sibr (Aloe barbadenesis) has been tested for gout treatment. It is an open clinical trial; conducted on 60 patients for duration of 60 days. Findings were recorded on a specially designed chart and inference was made by appropriate statistical analysis (Paired ‘t’ test). This result suggesting the effect of test drug is very effective in lowering the serum uric acid. Findings of trial were recorded on a specially designed chart and inference was made by appropriate statistical analysis.

The concept of hyperuricemia has not been described at all in Unani system of medicine, but description of a joint disorder known as Niqris, has been found in most of the classical Unani texts. The clinical features of Niqris very much resemble with the Gout as described in Allopathy, which occurs due to hyperuricemia. In practice, hyperuricemia is frequently defined as a serum urate levels exceeding of 7mg/dl (0.42 mmol/l) in adult males and 6 mg/dl (0.36 mmol/l) in adult females. However, this arbitrary definition of Hyperuricemia has been justified by epidemiological studies showing that those with SUA levels greater than 7mg/dl are at increased risk of developing gouty arthritis and urolithiasis. Hyperuricemia is fairly common, with a prevalence ranging between 2.3 to 41.4 percent in various populations. A variety of factors appear to be associated with higher serum urate concenterations. The present study was conducted on 50 patients of Primary Hyperuricemia attending the OPD of Ajmal Khan Tibbiya College and Hospital. During the study it was observed that the mean serum uric acid level, which was 8.6±1.1before the beginning of the study got reduced to 6.6±1.3 at the end of the study. As we applied paired “t” test to the observations recorded before and after treatment it was found that t=12.6, p